|Home | About | Journals | Submit | Contact Us | Français|
pVHL, the product of von Hippel-Lindau (VHL) tumor suppressor gene, functions as the substrate recognition component of an E3-ubiquitin ligase complex that targets hypoxia inducible factor α (HIF-α) for ubiquitination and degradation. Besides HIF-α, pVHL also interacts with other proteins and has multiple functions. Here, we report that pVHL inhibits ribosome biogenesis and protein synthesis. We find that pVHL associates with the 40S ribosomal protein S3 (RPS3) but does not target it for destruction. Rather, the pVHL-RPS3 association interferes with the interaction between RPS3 and RPS2. Expression of pVHL also leads to nuclear retention of pre-40S ribosomal subunits, diminishing polysomes and 18S rRNA levels. We also demonstrate that pVHL suppresses both cap-dependent and cap-independent protein synthesis. Our findings unravel a novel function of pVHL and provide insight into the regulation of ribosome biogenesis by the tumor suppressor pVHL.
Protein synthesis is a fundamental cell process with ribosomes assigned the task of decoding the genetic code. Ribosome biogenesis is exceptionally complex and in eukaryotic cells occurs mainly in the nucleolus requiring a myriad of proteins. The pathway begins with transcription of ribosomal proteins and ribosomal RNA (rRNA) precursors. The association of ribosomal proteins and non-ribosomal factors with nascent pre-rRNAs gives birth to a 90S pre-ribosomal complex. The 90S complex separates into a pre-60S complex that will yield the large ribosomal subunit and a pre-40S complex that will generate the small ribosomal subunit (1–3).
Ribosome production is enhanced in cancer cells and associated with profound quantitative and qualitative alterations in ribosomal biogenesis and function (4). Indeed, the synthesis of rRNAs, as well as the production of several ribosomal proteins, is up-regulated in a variety of tumors (5). As well, several tumor suppressors and oncogenes influence the formation of ribosomes. For example, loss of two major tumor suppressor gene products, the retinoblastoma protein (pRB) and p53, stimulates ribosome biogenesis in cancer cells (6). pRB is a suppressor of rRNA synthesis (7, 8) and p53 inhibits ribosome biogenesis through repressing the transcription of both RNA polymerase I and III (9). Notably, phosphatase and tensin homolog deleted in chromosome 10 (PTEN) also represses polymerase I transcription and MYC increases polymerase I activity and transcription of polymerase II and III genes (10). However, mechanistic links between these aforementioned events and ribosome assembly is lacking. Eukaryotic ribosome assembly is dependent on the presence of a large number of rRNA precursors and ~190 proteins have been implicated in eukaryotic ribosome biogenesis, stemming from the initial nucleolar steps to final processing in the cytoplasm (11, 12). These pre-ribosomal factors are, for the most part, essential for ribosome biogenesis (11).
Silencing or mutation of the von Hippel-Lindau (VHL)2 tumor suppressor gene leads to a variety of tumors, including the clear cell renal carcinoma, pheochromocytoma, hemangioblastoma, and polycythemia (13, 14). pVHL, the product of VHL, is an adaptor protein implicated in many biological processes (15). For example, it functions as the substrate recognition component of an E3-ubiquitin ligase complex that targets hypoxia inducible factor 1α (HIF-1α) for ubiquitination and destruction (16). pVHL regulates the stability of microtubules (17), primary cilium maintenance (18), cell differentiation (19), NF-κB activity (20), and Wnt signaling (21). Besides HIF-1α, pVHL has been found to bind to a dozen different proteins, such as atypical protein kinase C (22), hydroxylated α-chain of collagen IV (23), fibronectin (24), and Pax2 (25). Here, we report that pVHL associates with pre-ribosomes by binding the 40S ribosomal protein S3 (RPS3) and suppresses ribosome biogenesis, leading to inhibition of protein synthesis. Our results unravel a new property of pVHL and implicate it in the regulation of protein synthesis. As well, these findings provide novel insight into the regulation of ribosome biogenesis by a tumor suppressor gene product.
Human renal carcinoma 786-O and A498 cells were maintained in RPMI 1640. Human cervical cancer HeLa cells and human embryonic kidney 293T cells were cultured in DMEM. All media were supplemented with 10% fetal bovine serum, 100 units/ml of penicillin, and 100 μg/ml of streptomycin. The cells were cultured at 37 °C in 5% CO2 incubator.
The genes encoding the ribosomal proteins were obtained by reverse transcription-polymerase chain reaction and cloned into pcDNA3.1-myc vector. The truncated pVHL was cloned with a C-terminal Myc tag into pcDNA3.1. The vectors encoding HA-VHL-NES and HA-VHL-NESM were generated as described (26, 27). Briefly, HA-VHL-NES and HA-VHL-NESM fusions were produced by fusion of HA-VHL at its C terminus to the strong nuclear export signal (NES) of HIV Rev, LPPLERLTL, or to a mutated form of NES (NESM), LPPRERLTL (the underlined amino acid indicates the mutated change). Non-ribosome factors hNob1, hLtv1, and hEnp1 were cloned into pcDNA3.0, pcDNA3.1, or pCMVTag2B. Vectors encoding glutathione S-transferase (GST) tag or His tag fusion proteins were constructed by inserting PCR-generated fragments into pGEX4T1 or pET28a. The Escherichia coli BL21-Gold(DE3)pLysS cells were transformed with pGEX4T1 or pET28a expression vectors and treated with 0.1 mm isopropyl d-thiogalactoside for 4 h at 37 °C. Bicistronic luciferase reporter plasmids pGL3-Ren-CrPV-FF(Ren/CrPV-FF) and pcDNA-Ren-HCV-FF(Ren/HCV-FF) were as described (28).
Transient transfection was performed using Lipofectamine 2000 (Invitrogen) as per the manufacturer's instructions. To obtain stable transfectants, the cells were transfected and 24 h later were switched to medium containing G418 (600 μg/ml), which was changed every 2–3 days. After 3 weeks, G418-resistant stable monoclonal cell lines were chosen for further study.
Extracts were prepared by lysing cells on ice for 30 min in RIPA buffer (100 mm Tris, 150 mm NaCl, 1% Triton, 1% deoxycholic acid, 0.1% SDS, 1 mm EDTA, and 2 mm NaF, pH 7.5) supplemented with 1 mm sodium vanadate, 1 mm leupeptin, 1 mm aprotinin, 1 mm phenylmethylsulfonyl fluoride, 1 mm dithiothreitol, and 1 mm pepstatin A. The supernatant was collected after centrifugation at 12,000 × g for 15 min. Equal amounts of protein were resolved by SDS-PAGE and transferred to a nitrocellulose membrane. Proteins of interest were detected by Western blot using specific antibodies. Immunoprecipitation was performed as follows: 500 μg of cell lysates were incubated with 1 μg of primary antibody at 4 °C for 3 h. Twenty microliters of protein A/G-agarose beads was added and the incubation continued overnight. The beads were washed with ice-cold cell lysis buffer and boiled in SDS-PAGE loading buffer for 5 min before electrophoresis. Antibodies against pVHL, RPS3, RPL11, and RPS6 were from Cell Signaling. HA, nNob1, hEnp1/bystin-like, and Myc antibodies were purchased from Santa Cruz Biotechnology. β-Actin and FLAG antibodies were from Sigma.
The bacterial cells were lysed using the following buffer: 20 mm Tris-Cl, 2 mm EDTA, 150 mm NaCl, and 0.5% Nonidet P-40, pH 7.5. To monitor the interaction between pVHL and ribosomal proteins, bacterial lysates containing GST fusion proteins were incubated with glutathione-Sepharose 4B beads at 4 °C for 1 h. The beads were washed and incubated with His-tagged proteins. After washing, pVHL and the bound ribosomal proteins were eluted from the beads and subjected to electrophoresis.
For sucrose density gradient fractionation of ribosomes, cells were scraped and collected after adding cycloheximide (100 μg/ml) in culture for 5 min. Cells were then lysed using 0.5% Nonidet P-40 lysis buffer containing 100 mm KCl, 10 mm MgCl2, 100 μg/ml of cycloheximide, 100 units/ml of RNasin, 1 mm DTT and protease inhibitors (1 mm leupeptin, 1 mm pepstatin A, and 1 mm phenylmethylsulfonyl fluoride) for 15–20 min at 4 °C. The lysates were centrifuged at 8,000 × g for 5 min and the supernatants were collected. Equivalent A254 units of total lysate was loaded on a 10–45% linear sucrose gradient and centrifuged at 36,000 × g for 3 h at 4 °C using a Beckman SW40Ti rotor. Fractions were collected and absorbance at A254 was monitored.
For monitoring cap-dependent and cap-independent translations, cells were transiently transfected with the bicistronic luciferase reporter and pVHL expression plasmids. After harvesting, luciferase light units were measured using a dual luciferase assay kit following the manufacturer's recommendation (Promega). For monitoring global protein synthesis, an equal number of 786-O and A498 cells were incubated in methionine-free DMEM for 45 min, followed by addition of 10 μCi/well of [35S]methionine (PerkinElmer Life Sciences) for 60 min. Whole cell lysates were prepared and 30–40 μg of protein were loaded onto a 10% SDS-polyacrylamide gel. The proteins resolved on the gel were transferred to a nitrocellulose membrane and 35S-labeled proteins were visualized by autoradiography.
The VHL siRNA oligonucleotides (siVHL-1 and 2) and control siRNA oligonucleotides were designed as described (25) and purchased from GenePharma (Shanghai, China). The sense sequences of these oligonucleotides were: control, 5′-UUCUCCGAACGUGUCACGUTT-3′; siVHL-1, 5′-GCCAGUGUAUACUCUGAAATT-3′; and siVHL-2, 5′-GCUCUACGAAGAUCUGGAATT-3′.
Total RNA was isolated using TRIzol reagent and Northern blot was performed using the DIG Northern Starter Kit as per the manufacturer's instructions (Roche Applied Science). In brief, 10 μg of RNA was resolved by formamide-agarose gel electrophoresis and blotted onto a Hybond-N membrane. Pre-hybridization and hybridization with digoxigenin-labeled oligonucleotides was carried out overnight at 60 °C in hybridization buffer. After hybridization, the blot was washed twice with 2× SSC buffer, and twice in 0.1× SSC for 30 min. Both buffers contained 0.1% SDS. The membrane was incubated 30 min with anti-DIG-AP and then exposed to x-ray film. The sequences of the probes used for Northern blot analysis are: 5′-ITS1, 5′-DIG-CCTCGCCCTCCGGGCT CCGTTAATTGATC-3′; 18S, 5′-DIG-AT CGGCCCGAGGTTATCTAGAGTCACCAAA-3′; 28S, 5′-DIG-CCTCTTCGGGGGACGCGCGCGTGGCCCCGA-3′.
Cells were grown on glass coverslips, washed with phosphate-buffered saline (PBS), and fixed using formaldehyde (4%) for 20 min, followed by permeabilization with 0.1% Triton X-100. After washing with PBS, the coverslips were blocked in 3% BSA for 1 h, followed by an incubation with primary antibody (in 3% BSA) at 4 °C overnight. The coverslips were washed and incubated with fluorescence dye-conjugated secondary antibody for 30 min. Finally, the cells were stained with DAPI for 3 min in the dark. The stained cells were mounted and observed using a Zeiss LSM 510 META (Axiovert 200) microscope.
To identify pVHL-interacting proteins, we purified pVHL from 293T cells engineered to produce Myc-tagged pVHL. pVHL was pulled down from cell extracts using an anti-Myc antibody. The immunoprecipitates were resolved on SDS-polyacrylamide gels, and co-purifying proteins were collected and sent for mass spectrometry (MS) analysis (Fig. 1A). Among the peptides identified, we noted the presence of ribosomal proteins, containing both RPSs and 60S subunit ribosomal proteins (RPLs) (supplemental Table S1). Herein, we focus on characterizing the relationship between pVHL and these ribosomal components.
We first validated that pVHL interacted with ribosomal protein. RPS3 has the highest relative abundance among the identified ribosomal proteins in MS, we therefore detected whether pVHL associated with RPS3. Other proteins such as RPS3a and RPS6 were also examined. 293T cells were co-expressed with HA-tagged pVHL and Myc-tagged versions of RPS3, RPS3a, and RPS6. The results indicate that HA-pVHL associates with Myc-RPS3, Myc-RPS3a, and Myc-RPS6 (Fig. 1B). To determine whether any of these interactions were direct, we performed in vitro pulldown assays with GST or GST-VHL (Fig. 1C). Under our conditions, only His-RPS3 bound GST-pVHL (Fig. 1C). Given that these results suggest a direct interaction between pVHL and RPS3, we probed for, and detected such an association between the endogenous protein pairs in both 293T and HeLa cells (Fig. 1D). Overexpression of pVHL did not reduce the protein level of RPS3 (Fig. 1E), but decreased that of HIF-1α, a well known target of pVHL (supplemental Fig. S1), implying that pVHL does not target RPS3 for destruction. In addition, we found that the β domain of pVHL was sufficient for mediating the pVHL-RPS3 interaction (supplemental Fig. S2).
The above results suggested that pVHL interacts with components of the 40S subunits. We then examined whether pVHL was associated with ribosomal complexes. 293T cell extract was centrifuged on a sucrose gradient followed by a Western blot (Fig. 2A). pVHL co-sedimented with 40S complexes (40S and pre-40S subunits) and 80S complexes (80S and pre-90S ribosome). pVHL was not in fractions containing polysomes (fractions 14–18), suggesting that pVHL is not associated with the mature translating ribosomes. Similar results were obtained in HeLa cells (supplemental Fig. S3A). We immunoprecipitated pVHL from pooled fractions 1–4 (non-ribosomal fractions) and fractions 9–12 (80S/90S-conaining fractions) and probed for the presence of RPS3 and RPS6. The results show that pVHL was associated with RPS3 and RPS6 when in 80S/90S-containing fractions (supplemental Fig. S3B). These provide more evidence that pVHL associates with ribosomal complexes.
The hEnp1 (bystin-like) and hNob1 are human homologues of Saccharomyces cerevisiae Enp1p and Nob1 that are components of pre-40S and pre-90S particles in yeast (29–34). Location of hEnp1 and hNob1 was determined and the results show that both proteins and pVHL were sedimented in fractions 5–6 and 9–11 (Fig. 2A). The hEnp1 and hNob1 do not display the same profiles as each other. Nob1 was found in polysome-containing fractions (Fig. 2A). It is reported that the immature small ribosomal subunits can engage in translation initiation and the putative endonuclease Nob1, which is specific to late pre-40S particles can interact with polysomes (35, 36). This is one possible reason why Nob1 was detected in polysome fractions.
Meanwhile, we found that pVHL was associated with hEnp1 and hNob1 (Fig. 2B). The pVHL was also found to interact with another pre-ribosomal protein hLtv1 (human homologue of S. cerevisiae Ltv1p) (29–34) (Fig. 2B). Notably, hNob1, hEnp1, and hLtv1 are implicated in ribosome assembly but not part of mature ribosomes because they are released in the cytoplasm before ribosome maturation is completed (29–34). Altogether, the results suggest that pVHL is present in 40S and 90S precursors.
RNase can degrade ribosomal RNA and disrupt the ribosomal complex. We found that RNase treatment did not affect the interaction between pVHL and RPS3 (Fig. 2C), but abolished the interaction between pVHL and RPS3a or RPS6 (Fig. 2D). These results indicate that the association between pVHL and ribosomal precursors is through the stable interaction with RPS3.
We were interested in assessing the function of pVHL binding to ribosomes. Given the association of pVHL with pre-ribosomal complexes, we asked whether pVHL could be playing a role in ribosome biogenesis. To address this, we took advantage of VHL-null renal carcinoma 786-O cells. The cells were transfected with control empty vector or an HA-VHL expression vector, and stable transfectants were selected. Extracts from 786-O(control) and 786-O(VHL) cells were prepared and ribosomal content was assessed by fractionation using sucrose gradient centrifugation. Re-introduction of VHL into 786-O cells led to a reduction in the polysomes (Fig. 3A). We found that the polysome to monosome ratio (P/M) in 786-O(VHL) cells was decreased compared with that in 786-O cells (Fig. 3A). These data suggest that pVHL reduces the amount of mature ribosomes.
To know whether pVHL affects ribosome maturation, we performed Northern blot analysis to determine the quantity of rRNAs. In mammals, the 40S subunit is composed of 18S rRNA, whereas the 60S subunit is made up of the 28S, 5.8S, and 5S rRNAs. These rRNAs are first synthesized as precursor rRNA (pre-rRNA) molecules that undergo extensive processing to produce mature and functional rRNA (Fig. 3B) (37, 38). We examined pre-rRNA processing by using probes directed against the 18S rRNA, 28S rRNA, and the 5′-most nucleotides of the ITS1 (5′-ITS1). RNA was isolated from 786-O cells ectopically expressing pVHL and analyzed by Northern blot. The results indicate that levels of 18S rRNA, but not 28S rRNA, in 786-O(VHL) cells are lower than those in 786-O(control) cells (Fig. 3C). A498 (another VHL-null renal carcinoma) cells were examined and similar results were obtained (Fig. 3C). Knockdown of pVHL enhanced 18S rRNA levels in 293T cells (Fig. 3D). Previously, it has been reported that acidosis-dependent nucleolar condensation and restriction of rDNA transcription requires nucleolar pVHL (39). We determined the effect of pVHL on rDNA transcription in our system and the results indicate that overexpression of pVHL had little effect on the level of pre-rRNA (supplemental Fig. S4A). In addition, we found that the 21S precursor rRNAs were accumulated and 18S-E was reduced in 786-O(VHL) cells (Fig. 3E).
Initiation of 18S rRNA processing is strictly dependent on the assembly of a subset of initiation-RPS proteins, such as RPS3a, RPS4, and RPS6. Progression of the nuclear and cytoplasmic maturation steps is dependent on a different set of RPS proteins, including RPS2, RPS15, and RPS21. RPS3 is one of the intermediate associating proteins, which links the early associating initiation-RPS proteins and late-associating progression-RPS proteins (40). Depletion of RPS2 delays pre-rRNA processing and leads to the accumulation of 20S pre-rRNA in yeast (41, 42) and 21S pre-rRNA in human (40). The data of Fig. 3E are consistent with this. In the 40S ribosomal subunits, RPS2 is directly associated with RPS3 (43, 44). We therefore supposed that pVHL might prevent RPS2 from binding to the pre-ribosomal complex. We do find that pVHL suppressed the interaction between RPS3 and RPS2 (Fig. 3F), but not the interaction between RPS3 and the initiation protein RPS3a (supplemental Fig. S4B). We examined whether depletion of RPS2 could lead to reduction of 18S rRNA and found that knockdown of RPS2 reduced 18S rRNA (supplemental Fig. S4C). In addition, we determined the expression of RPS2 by the ribosome profile assay in 786-O(VHL) and control cells. A reduction of RPS2 was observed in the 40S sized fractions of 786-O(VHL) cells (supplemental Fig. S4D). These results suggest that pVHL impairs 40S ribosome biogenesis through suppressing the RPS2-RPS3 interaction.
The assembly of the ribosomal subunits is completed in the cytoplasm. Blockade of the ribosome assembly could be arising as a consequence of accumulation of ribosome proteins in the nucleus. As seen in Fig. 3B, most of the 18S precursors are found exclusively in the nucleus, including the 21S pre-rRNA. Moreover, the last precursor 18S-E pre-rRNA is exported from the nucleus and processed to 18S rRNA in cytoplasm (38). To determine whether reduction of 18S-E rRNA in pVHL overexpression cells could lead to the pre-40S subunits retention in the nucleus, we detected subcellular localization of the 40S ribosomal protein RPS3 and pre-40S factor hLtv1. To this end, we utilized expression vectors encoding pVHL, pVHL-NES, and pVHL-NESM. pVHL and pVHL-NESM can freely enter into the nucleus, but pVHL-NES is nuclear-import defective (26, 27). Overexpression of pVHL and pVHL-NESM, but not pVHL-NES, enhanced RPS3 (Fig. 4A) and hLtv1 (Fig. 4B) levels in the nucleus. These results suggest that pVHL leads to nuclear retention of pre-40S precursors. Western blot results confirmed the nuclear accumulation of RPS3 and RPS6 in 786-O cells that stably expressed pVHL (Fig. 4C). Expression of pVHL had little effect on nuclear levels of the 60S subunit ribosomal protein RPL11 (Fig. 4C and supplemental Fig. S5A). Interestingly, the protein levels of RPS3 and RPS6 were found decreased in the cytoplasm (Fig. 4C). However, the total protein levels of RPS3 and RPS6 were not affected (Fig. 4D). The reduction of polysomes described in Fig. 3A could be the consequence of the retention of pre-40S in the nucleus and the lack of 40S subunits in the cytoplasm to form mature 80S ribosomes.
We have shown that pVHL suppressed the interaction of RPS3 and RPS2 (Fig. 3F) and RPS2 depletion led to 18S rRNA reduction (supplemental Fig. S4C). We therefore examined whether depletion of RPS2 could also result in pre-40S subunit sequestration. We found that inhibition of RPS2 led to nuclear sequestration of RPS3, RPS6, and hENP1 (supplemental Fig. S5B). Deletion of RPS2 had little effect on RPL11 nuclear and cytoplasm distribution.
Our results suggest that pVHL suppresses ribosome biogenesis. We next determined the effects of pVHL on global protein synthesis. We therefore assessed the effects of pVHL on translation using the bicistronic luciferase reporter plasmid (Fig. 5A). Overexpression of pVHL inhibited both cap-dependent Renilla luciferase (REN) translation and CrPV internal ribosome entry site-mediated (CrPV IRES-mediated) translation of firefly luciferase (FF) (Fig. 5B). Another luciferase reporter plasmid Ren/HCV/FF (HCV-IRES-mediated) (28) was employed and similar results were obtained (supplemental Fig. S6A). The result was not a consequence of effects on integrity of reporter mRNA (supplemental Fig. S6B). The translation repressor protein 4E-BP1 controls translation initiation (45). We found that pVHL had little effect on expression and phosphorylation of 4E-BP1 (Fig. 5C).
Moreover, suppression of VHL by RNA interference enhanced both cap-dependent and cap-independent protein translations (Fig. 5D and supplemental Fig. S7A). Because RPS3 binds pVHL at the β domain (supplemental Fig. S2), we assessed if this domain was also responsible for the observed inhibition of translation. We found that pVHL and pVHL(1–155) inhibited translation (Fig. 5E). However, pVHL(Δ63–113), pVHL(Δ63–155), and pVHL(Δ114–155) had little effect on translation (Fig. 5E). These mutations had little effect on the nucleus location of pVHL (supplemental Fig. S8). We also assessed whether altered subcellular localization of pVHL would have an effect on its ability to inhibit protein synthesis. The results show that pVHL and pVHL-NESM, but not pVHL-NES, inhibit translation (Fig. 5F and supplemental Fig. S7B).
Next, we determined whether pVHL was exerting an inhibition effect on global protein synthesis by performing [35S]methionine labeling of cells lacking or expressing wild-type pVHL (Fig. 6A). We noted that re-introduction of VHL into 786-O and A498 cells repressed global protein synthesis (Fig. 6A). Consistent with this, re-expression of VHL in 786-O and A498 cells attenuated proliferation of both cells (Fig. 6B).
Ribosome production is enhanced in cancer cells and the enhanced ribosome production may facilitate tumorigenesis (4, 5, 9). The mechanisms of up-regulation of ribosome biogenesis in cancer cells remain unclear. Several tumor suppressors and oncogenes have been found to influence the formation of ribosomes. pRB and p53 influence ribosome biogenesis through inhibiting rRNA synthesis and RNA polymerases transcription (6–9). PTEN represses transcription of polymerase I and MYC increases transcription of polymerase I, II, and III (10). In this article, we demonstrate that pVHL inhibits ribosome biogenesis through interfering with the assembly of ribosomes.
As an adaptor protein, pVHL interacts with many proteins (15). The identification of interacting proteins has helped to elucidate the multiple functions of pVHL. For example, the function of pVHL to block assembly of the extracellular fibronectin matrix has been linked to its ability to bind fibronectin (24). We find that RPS3 is a new interacting protein of pVHL. In this report we provide data that suggests that pVHL binds RPS3 and interferes with ribosome assembly. Besides RPS3, other ribosomal proteins were also identified in our MS assay (supplemental Table S1). In ribosome biogenesis, the 90S precursor contains the processed versions of ribosomal proteins (RPSs and RPLs) and RPS3 was identified in 90S precursors (31). pVHL directly binds RPS3 and therefore it can associate with the 90S precursors. So, it is expected that pVHL may have indirect interaction with other proteins in 90S particles.
pVHL is co-sedimented with pre-40S ribosomal subunits and impaired 18S rRNA processing (Figs. 2 and and33C), indicating that pVHL inhibits biogenesis of ribosomal small subunits. RPS2 is a progression-RPS protein that is necessary for nuclear export and cytoplasmic maturation steps (38). We found that depletion of RPS2 reduced 18S rRNA (supplemental Fig. S4D) and led to nuclear sequestration of RPS3, RPS6, and hEnp1, which indicates the nuclear retention of pre-40S subunits (supplemental Fig. S5A). Overexpression of pVHL prevents the interaction between RPS3 and RPS2 (Fig. 3F), leading to 18S rRNA reduction (Fig. 3) and nuclear retention of pre-40S subunits (Fig. 4). These results suggest that pVHL suppresses 40S subunit assembly by preventing the RPS3-RPS2 interaction. pVHL had little effect on the 28S rRNA level (Fig. 3, C and D) and RPL11 cellular location (Fig. 4C and supplemental Fig. S5). Thus, pVHL might not influence 60S ribosomal subunits.
Overexpression of pVHL reduced polysomes (Fig. 3, supplemental Fig. S4D). Consistent with these results, pVHL was found to inhibit translation (Fig. 5, B and D, and supplemental Figs. S6A and S7A). Finally, we demonstrate that expression of pVHL inhibits protein synthesis in 786-O and A498 cells (Fig. 6). Taken together, our results suggest that pVHL inhibits global translation.
Ribosome biogenesis is an important process for a proliferating cell (46). The biological mechanisms that regulate cell proliferation also control ribosome biogenesis and have been linked to transformation. Up-regulation of ribosome biogenesis is associated with an increased risk of tumor onset and elevated ribosome biogenesis is associated with acquisition of the neoplastic phenotype (9). As a result of oncogene gain-of-function mutations or tumor suppressor loss, ribosome biogenesis is frequently enhanced and associated with a cellular growth advantage, although the mechanisms are unclear. We report here that pVHL inhibits ribosome biogenesis through ribosomal protein assembly. pVHL is a tumor suppressor and its loss is associated with tumor initiation and progression (13). Our results may uncover a new function of pVHL in regulation of tumor cell proliferation by controlling the ribosome biogenesis.
*This work was supported by Natural Science Foundation of China Grants 30970586 and 31270829 and the Innovation Program of Chinese Academy of Sciences Grant KSCX2-EW-R-09.
This article contains supplemental Table S1 and Figs. S1–S8.
2The abbreviations used are: